|
1
|
Lee HB, Yu MR, Yang Y, Jiang Z and Ha H:
Reactive oxygen species-regulated signaling pathways in diabetic
nephropathy. J Am Soc Nephrol. 14 8 Suppl 3:S241–S245. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nishikawa T and Araki E: Impact of
mitochondrial ROS production in the pathogenesis of diabetes
mellitus and its complications. Antioxid Redox Signal. 9:343–353.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Forbes JM, Coughlan MT and Cooper ME:
Oxidative stress as a major culprit in kidney disease in diabetes.
Diabetes. 57:1446–1454. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sedeek M, Callera G, Montezano A, Gutsol
A, Heitz F, Szyndralewiez C, Page P, Kennedy CR, Burns KD, Touyz RM
and Hébert RL: Critical role of Nox4-based NADPH oxidase in
glucose-induced oxidative stress in the kidney: Implications in
type 2 diabetic nephropathy. Am J Physiol Renal Physiol.
299:F1348–F1358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hancock JT, Desikan R and Neill SJ: Role
of reactive oxygen species in cell signalling pathways. Biochem Soc
Trans. 29:345–350. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Youn JY, Gao L and Cai H: The p47phox- and
NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH
oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS)
uncoupling and endothelial dysfunction in a streptozotocin-induced
murine model of diabetes. Diabetologia. 55:2069–2079. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jha JC, Thallas-Bonke V, Banal C, Gray SP,
Chow BS, Ramm G, Quaggin SE, Cooper ME, Schmidt HH and
Jandeleit-Dahm KA: Podocyte-specific Nox4 deletion affords
renoprotection in a mouse model of diabetic nephropathy.
Diabetologia. 59:379–389. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee DY, Wauquier F, Eid AA, Roman LJ,
Ghosh-Choudhury G, Khazim K, Block K and Gorin Y: Nox4 NADPH
oxidase mediates peroxynitrite-dependent uncoupling of endothelial
nitric-oxide synthase and fibronectin expression in response to
angiotensin II: Role of mitochondrial reactive oxygen species. J
Biol Chem. 288:28668–28686. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gorin Y, Cavaglieri RC, Khazim K, Lee DY,
Bruno F, Thakur S, Fanti P, Szyndralewiez C, Barnes JL, Block K and
Abboud HE: Targeting NADPH oxidase with a novel dual Nox1/Nox4
inhibitor attenuates renal pathology in type 1 diabetes. Am J
Physiol Renal Physiol. 308:F1276–F1287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eid AA, Lee DY, Roman LJ, Khazim K and
Gorin Y: Sestrin 2 and AMPK connect hyperglycemia to Nox4-dependent
endothelial nitric oxide synthase uncoupling and matrix protein
expression. Mol Cell Biol. 33:3439–3460. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Prabhakar S, Starnes J, Shi S, Lonis B and
Tran R: Diabetic nephropathy is associated with oxidative stress
and decreased renal nitric oxide production. J Am Soc Nephrol.
18:2945–2952. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen H, Zheng Z, Li R, Lu J, Bao Y, Ying
X, Zeng R and Jia W: Urinary pigment epithelium-derived factor as a
marker of diabetic nephropathy. Am J Nephrol. 32:47–56. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang JJ, Zhang SX, Mott R, Knapp RR, Cao
W, Lau K and Ma JX: Salutary effect of pigment epithelium-derived
factor in diabetic nephropathy: Evidence for antifibrogenic
activities. Diabetes. 55:1678–1685. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tombran-Tink J, Chader GG and Johnson LV:
PEDF: A pigment epithelium-derived factor with potent neuronal
differentiative activity. Exp Eye Res. 53:411–414. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tombran-Tink J and Barnstable CJ: PEDF: A
multifaceted neurotrophic factor. Nat Rev Neurosci. 4:628–636.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Becerra SP: Focus on molecules: Pigment
epithelium-derived factor (PEDF). Exp Eye Res. 82:739–740. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mao T, Gao L, Li H and Li J: Pigment
epithelium-derived factor inhibits high glucose induced oxidative
stress and fibrosis of cultured human glomerular mesangial cells.
Saudi Med J. 32:769–777. 2011.PubMed/NCBI
|
|
19
|
Gao L, Pung YF, Zhang J, Chen P, Wang T,
Li M, Meza M, Toro L and Cai H: Sepiapterin reductase regulation of
endothelial tetrahydrobiopterin and nitric oxide bioavailability.
Am J Physiol Heart Circ Physiol. 297:H331–H339. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Setsukinai K, Urano Y, Kakinuma K, Majima
HJ and Nagano T: Development of novel fluorescence probes that can
reliably detect reactive oxygen species and distinguish specific
species. J Biol Chem. 278:3170–3175. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sheikpranbabu S, Haribalaganesh R and
Gurunathan S: Pigment epithelium-derived factor inhibits advanced
glycation end-products-induced cytotoxicity in retinal pericytes.
Diabetes Metab. 37:505–511. 2011.PubMed/NCBI
|
|
22
|
Gao L, Huang W and Li J: NOX1 abet
mesangial fibrogenesis via iNOS induction in diabetes. Mol Cell
Biochem. 382:185–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng G and Lambeth JD: NOXO1, regulation
of lipid binding, localization, and activation of Nox1 by the Phox
homology (PX) domain. J Biol Chem. 279:4737–4742. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Liu W, Wang Q, Liu P, Deng Y, Lan T,
Zhang X, Qiu B, Ning H and Huang H: Emodin suppresses cell
proliferation and fibronectin expression via p38MAPK pathway in rat
mesangial cells cultured under high glucose. Mol Cell Endocrinol.
307:157–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ho C, Lee PH, Huang WJ, Hsu YC, Lin CL and
Wang JY: Methylglyoxal-induced fibronectin gene expression through
Ras-mediated NADPH oxidase activation in renal mesangial cells.
Nephrology (Carlton). 12:348–356. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu CM, Qi XL, Yang YF and Zhang XD:
Betulinic acid inhibits cell proliferation and fibronectin
accumulation in rat glomerular mesangial cells cultured under high
glucose condition. Biomed Pharmacother. 80:338–342. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fang S, Jin Y, Zheng H, Yan J, Cui Y, Bi
H, Jia H, Zhang H, Wang Y, Na L, et al: High glucose condition
upregulated Txnip expression level in rat mesangial cells through
ROS/MEK/MAPK pathway. Mol Cell Biochem. 347:175–182. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yuan Z, Feng W, Hong J, Zheng Q, Shuai J
and Ge Y: p38MAPK and ERK promote nitric oxide production in
cultured human retinal pigmented epithelial cells induced by high
concentration glucose. Nitric Oxide. 20:9–15. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shatanawi A, Lemtalsi T, Yao L, Patel C,
Caldwell RB and Caldwell RW: Angiotensin II limits NO production by
upregulating arginase through a p38 MAPK-ATF-2 pathway. Eur J
Pharmacol. 746:106–114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang J, Duh EJ, Caldwell RB and Behzadian
MA: Antipermeability function of PEDF involves blockade of the MAP
kinase/GSK/beta-catenin signaling pathway and uPAR expression.
Invest Ophthalmol Vis Sci. 51:3273–3280. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao S, Li C, Zhu Y, Wang Y, Sui A, Zhong
Y, Xie B and Shen X: PEDF mediates pathological neovascularization
by regulating macrophage recruitment and polarization in the mouse
model of oxygen-induced retinopathy. Sci Rep. 7:428462017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wen H, Liu M, Liu Z, Yang X, Liu X, Ni M,
Dong M, Luan X, Yuan Y, Xu X and Lu H: PEDF improves
atherosclerotic plaque stability by inhibiting macrophage
inflammation response. Int J Cardiol. 235:37–41. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pacher P and Szabo C: Role of the
peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.
Am J Pathol. 173:2–13. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kar S and Kavdia M: Endothelial NO and
O2− production rates differentially regulate
oxidative, nitroxidative, and nitrosative stress in the
microcirculation. Free Radic Biol Med. 63:161–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kouti L, Noroozian M, Akhondzadeh S,
Abdollahi M, Javadi MR, Faramarzi MA, Mousavi S and Ghaeli P:
Nitric oxide and peroxynitrite serum levels in Parkinson's disease:
Correlation of oxidative stress and the severity of the disease.
Eur Rev Med Pharmacol Sci. 17:964–970. 2013.PubMed/NCBI
|
|
36
|
Harrison DG, Chen W, Dikalov S and Li L:
Regulation of endothelial cell tetrahydrobiopterin
pathophysiological and therapeutic implications. Adv Pharmacol.
60:107–132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stern D, Yan SD, Yan SF and Schmidt AM:
Receptor for advanced glycation endproducts: A multiligand receptor
magnifying cell stress in diverse pathologic settings. Adv Drug
Deliv Rev. 54:1615–1625. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yamagishi S, Nakamura K, Matsui T, Noda Y
and Imaizumi T: Receptor for advanced glycation end products
(RAGE): A novel therapeutic target for diabetic vascular
complication. Curr Pharm Des. 14:487–495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schröder K, Weissmann N and Brandes RP:
Organizers and activators: Cytosolic Nox proteins impacting on
vascular function. Free Radic Biol Med. 109:22–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
